Karin Dill

Quantitative Analysis of ECG-Gated High-Resolution Contrast-Enhanced MR Angiography of the Thoracic Aorta

OBJECTIVE The purpose of this study was to evaluate the effect of cardiac gating on the quality of images of the thoracic aorta at various levels during contrast-enhanced MR angiography compared with MR angiography without cardiac gating. MATERIALS AND METHODS Fifty patients underwent high-resolution contrast-enhanced MR angiography on a 1.5-T whole-body system. The 50 patients were composed of two groups of 25 consecutive patients; one group underwent MR angiography with ECG gating and the other group underwent MR angiography without ECG gating. A sagittal (3D) gradient-echo fast low-angle shot (FLASH) sequence (TR/TE, 2.8/1.4; flip angle, 25 degrees; readout, 512; voxel size, 1.4 x 0.8 x 1.3 mm) with an asymmetric k-space scanning scheme in all three gradient axes was used, and 0.2 mmol/kg of gadopentetate dimeglumine was injected at 2 mL/s. Sharpness of the thoracic aorta was evaluated at three levels by generating a signal intensity profile across the aortic vessel wall and calculating the distance between two points along a line representing the slope of the signal intensity profile. Both sides of the intensity profile were analyzed and averaged and then used to calculate sharpness. An additional group of six patients was included who had undergone both a gated and an ungated sequence; results of this group were analyzed independently. RESULTS Quantitative analysis of the sharpness of the ascending thoracic aorta showed a significant increase in sharpness in both the 50-patient and six-patient groups (p < 0.005) with the addition of cardiac gating. CONCLUSION Cardiac gating significantly improves the sharpness of the ascending aorta, a portion of the aorta that is subject to a great deal of blurring caused by cardiac motion. High-resolution contrast-enhanced MR angiography with cardiac gating can produce high quality images of the thoracic vasculature, thus enabling accurate diagnosis of vessel disease.

Sample Size and Cost Analysis for Pulmonary Arterial Hypertension Drug Trials Using Various Imaging Modalities to Assess Right Ventricular Size and Function End Points

Background—Placebo-controlled trials for pulmonary arterial hypertension are no longer acceptable because new therapies must show clinically significant effects on top of standard treatment. The purpose of this study was to estimate sample sizes and imaging costs for the planning of a hypothetical pulmonary arterial hypertension drug trial using imaging to detect changes in right ventricular size and function in response to combined therapy. Methods and Results—Same-day cardiovascular MR (CMR) and 2-dimensional (2D) and 3D transthoracic echocardiography (2DTTE and 3DTTE) were performed in 22 patients with pulmonary arterial hypertension (54±13 years of age) twice, 6 months apart. Short-axis CMR cines and full-volume 3DTTE data sets of the right ventricle were used to measure end-diastolic volume and ejection fraction. Fractional area change was obtained from 2DTTE. Sample size calculations used a 2-sample t test model incorporating differences between baseline and 6-month measurements. Cost estimates were made using the Medicare fee schedule. No significant differences were noted between baseline and follow-up measurements. Large SDs reflected variable progression of disease in individual patients on standard therapy and measurement variability. These sources of variability resulted in intertechnique differences in sample sizes: to detect a change of 5% to 15% in 3DTTE-derived right ventricular ejection fraction and fractional area change or change of 15 to 30 mL in 3DTTE right ventricular end-diastolic volume; sample sizes were 2× to 2.5× those required by CMR. As a result, the total cost of a trial using complete TTE was greater than CMR, which was greater than limited TTE. Conclusions—Because of lower measurement variability, CMR is more cost saving in pulmonary arterial hypertension drug trials than echocardiography, unless limited TTE is used.

Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson

BackgroundAdenosine cardiovascular magnetic resonance (CMR) can accurately quantify myocardial perfusion reserve. While regadenoson is increasingly employed due to ease of use, imaging protocols have not been standardized. We sought to determine the optimal regadenoson CMR protocol for quantifying myocardial perfusion reserve index (MPRi) – more specifically, whether regadenoson stress imaging should be performed before or after rest imaging.MethodsTwenty healthy subjects underwent CMR perfusion imaging during resting conditions, during regadenoson-induced hyperemia (0.4 mg), and after 15 min of recovery. In 10/20 subjects, recovery was facilitated with aminophylline (125 mg). Myocardial time-intensity curves were used to obtain left ventricular cavity-normalized myocardial up-slopes. MPRi was calculated in two different ways: as the up-slope ratio of stress to rest (MPRi-rest), and the up-slope ratio of stress to recovery (MPRi-recov).ResultsIn all 20 subjects, MPRi-rest was 1.78 ± 0.60. Recovery up-slope did not return to resting levels, regardless of aminophylline use. Among patients not receiving aminophylline, MPRi-recov was 36 ± 16% lower than MPRi-rest (1.13 ± 0.38 vs. 1.82 ± 0.73, P = 0.001). In the 10 patients whose recovery was facilitated with aminophylline, MPRi-recov was 20 ± 24% lower than MPRi-rest (1.40 ± 0.35 vs. 1.73 ± 0.43, P = 0.04), indicating incomplete reversal. In 3 subjects not receiving aminophylline and 4 subjects receiving aminophylline, up-slope at recovery was greater than at stress, suggesting delayed maximal hyperemia.ConclusionsMPRi measurements from regadenoson CMR are underestimated if recovery perfusion is used as a substitute for resting perfusion, even when recovery is facilitated with aminophylline. True resting images should be used to allow accurate MPRi quantification. The delayed maximal hyperemia observed in some subjects deserves further study.Trial registrationClinicalTrials.gov NCT00871260

Time-resolved MR angiography with generalized autocalibrating partially parallel acquisition and time-resolved echo-sharing angiographic technique for hemodialysis arteriovenous fistulas and grafts.

PURPOSE To evaluate the imaging of hemodialysis arteriovenous (AV) fistulas and grafts with use of magnetic resonance (MR) angiography with generalized autocalibrating partially parallel acquisition (GRAPPA) and time-resolved echo-sharing angiographic technique (TREAT) and compare the findings with those of digital subtraction angiography (DSA). MATERIALS AND METHODS The vascular tree directly related to AV fistulas and grafts was divided into nine segments. Images of each segment obtained on GRAPPA MR angiography were evaluated for the presence of stenosis, occlusion, and any other disease (eg, pseudoaneurysm) by two independent observers and compared with a consensus reading of the same segments on DSA imaging. Sensitivity and specificity were calculated with use of DSA as the gold standard modality, and each image on MR angiography and DSA was rated for quality. Linear-weighted kappa scores were calculated as a measure of interobserver variability in the detection of pathologic processes. RESULTS A total of 80 segments were evaluated by each observer. For both observers, sensitivity rates for the detection of stenosis, occlusion, and any disease were 100% (95% CI, 52%-100%), 100% (95% CI, 20%-100%), and 100% (95% CI, 60%-100%), respectively. For observer 1, specificity rates for the detection of stenosis, occlusion, and any disease were 96% (95% CI, 88%-99%), 100% (95% CI, 94%-100%), and 96% (95% CI, 88%-99%), respectively. For observer 2, the specificity rates for the detection of stenosis, occlusion, and any disease were 93% (95% CI, 84%-98%), 100% (95% CI, 94%-100%), and 93% (95% CI, 84%-97%), respectively. Linear-weighted kappa values for MR angiography and DSA were 0.78+/-0.084 and 0.62+/-0.152, respectively. CONCLUSION Time-resolved MR angiography with GRAPPA and TREAT offers excellent image quality and provides an accurate and reliable modality for the detection of pathologic processes in hemodialysis AV fistulas and grafts.

Orthogonal measurement of thoracic aorta luminal diameter using ECG‐gated high‐resolution contrast‐enhanced MR angiography

To compare orthogonal measurements of the thoracic aortic luminal diameter to standard axial measurements within the same patient population using ECG‐gated high‐resolution contrast‐enhanced MR angiography (CE‐MRA).

Right Ventricular Strain in Pulmonary Arterial Hypertension: A 2D Echocardiography and Cardiac Magnetic Resonance Study

Right ventricular (RV) strain is a potentially useful prognostic marker in patients with pulmonary arterial hypertension (PAH). However, published reports regarding the accuracy of two‐dimensional echocardiography (2DE)‐derived RV strain against an independent reference in this patient population are limited. The aims of this study were: (1) to study the relationship between 2DE RV longitudinal strain and cardiovascular magnetic resonance (CMR)‐derived RV ejection fraction (RVEF) in patients with PAH; (2) to compare 2DE‐derived and CMR‐derived RV longitudinal strain in these patients; and (3) to determine the reproducibility of these measurements.

ACR Appropriateness Criteria® Imaging for Transcatheter Aortic Valve Replacement

Although aortic valve replacement is the definitive therapy for severe aortic stenosis, almost half of patients with severe aortic stenosis are unable to undergo conventional aortic valve replacement because of advanced age, comorbidities, or prohibitive surgical risk. Treatment options have been recently expanded with the introduction of catheter-based implantation of a bioprosthetic aortic valve, referred to as transcatheter aortic valve replacement. Because this procedure is characterized by lack of exposure of the operative field, image guidance plays a critical role in preprocedural planning. This guideline document evaluates several preintervention imaging examinations that focus on both imaging at the aortic valve plane and planning in the supravalvular aorta and iliofemoral system. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

Coronary Artery Disease - Reporting and Data System (CAD-RADS): An Expert Consensus Document of SCCT, ACR and NASCI: Endorsed by the ACC

The intent of CAD-RADS - Coronary Artery Disease Reporting and Data System is to create a standardized method to communicate findings of coronary CT angiography (coronary CTA) in order to facilitate decision-making regarding further patient management. The suggested CAD-RADS classification is applied on a per-patient basis and represents the highest-grade coronary artery lesion documented by coronary CTA. It ranges from CAD-RADS 0 (Zero) for the complete absence of stenosis and plaque to CAD-RADS 5 for the presence of at least one totally occluded coronary artery and should always be interpreted in conjunction with the impression found in the report. Specific recommendations are provided for further management of patients with stable or acute chest pain based on the CAD-RADS classification. The main goal of CAD-RADS is to standardize reporting of coronary CTA results and to facilitate communication of test results to referring physicians along with suggestions for subsequent patient management. In addition, CAD-RADS will provide a framework of standardization that may benefit education, research, peer-review and quality assurance with the potential to ultimately result in improved quality of care.

Breathhold time-resolved three-directional MR velocity mapping of aortic flow in patients after aortic valve-sparing surgery

To evaluate the utility of breathhold time‐resolved three‐directional MR velocity mapping for quantifying the restoration of normal flow patterns in patients after aortic valve‐sparing surgery.

ACR Appropriateness Criteria Imaging in the Diagnosis of Thoracic Outlet Syndrome

Thoracic outlet syndrome is a clinical entity characterized by compression of the neurovascular bundle, and may be associated with additional findings such as venous thrombosis, arterial stenosis, or neurologic symptoms. The goal of imaging is to localize the site of compression, the compressing structure, and the compressed organ or vessel, while excluding common mimics. A literature review is provided of current indications for diagnostic imaging, with discussion of potential limitations and benefits of the respective modalities. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. In this document, we provided guidelines for use of various imaging modalities for assessment of thoracic outlet syndrome.